News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News Digital Heroes Marks 2,000 Brand Launches Across 55 Countries Through Global Technology Services News ANT Law Firm Strengthens Its Orlando Legal Services for Car Accident, Slip and Fall, and Wrongful Death Victims News LumenIsle Launches Australian Market Service Review and International Video Traceability Initiative for Memorial Diamonds News HiBob Named Best HR Management Software in the UK for 2026 News Ionik Announces 30-Day Extension of Senior Debt Facility News NTG Clarity to Announce First Quarter Financial Results on May 27, 2026 with Earnings Call to Follow
